VKA

DRUG10 trials

Conditions

AnticoagulationAntiphospholipid SyndromeAtrial FibrillationAtrial Fibrillation (AF)Bleeding Post Cardiac SurgeryCoronary Artery DiseaseEmbolismIndication for Anticoagulation

Early Phase 1

DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial

Not yet recruitingNCT07011095

Population Health Research InstituteAtrial Fibrillation (AF), Stroke (in Patients With Atrial Fibrillation)

Start: 2025-09-03End: 2027-06-03Target: 100Updated: 2025-06-08

Phase 2

A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS)

WithdrawnNCT07172022

Hoffmann-La RocheAntiphospholipid Syndrome

Start: 2026-03-16End: 2030-12-02Updated: 2026-03-02

Phase 3

Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants

TerminatedNCT02664155

Centre Hospitalier Universitaire de Saint EtienneRenal Insufficiency

Start: 2016-10-19End: 2022-05-30Updated: 2022-10-19

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

RecruitingNCT04284839

Population Health Research InstituteBleeding Post Cardiac Surgery, Indication for Anticoagulation

Start: 2021-07-18End: 2027-06-30Target: 3500Updated: 2025-09-29

Unknown Phase

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

CompletedNCT02640222

Bristol-Myers SquibbAnticoagulation

Start: 2014-01-01End: 2019-12-31Updated: 2022-05-18

Health-related Quality of Life in Patients on Anticoagulants

CompletedNCT03134911

Boehringer IngelheimAtrial Fibrillation

Start: 2017-04-24End: 2018-01-31Updated: 2019-04-18

The Greek AntiPlatElet Atrial Fibrillation Registry.

CompletedNCT03362788

Attikon HospitalAtrial Fibrillation, Coronary Artery Disease

Start: 2017-12-01End: 2020-12-31Updated: 2021-07-26

Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf)

CompletedNCT03441633

PfizerAtrial Fibrillation

Start: 2016-02-18End: 2017-03-08Updated: 2023-06-09

Anticoagulation in Patients With Venous Thromboembolism and Cancer

Active, not recruitingNCT04618913

PfizerEmbolism, Neoplasms

Start: 2020-12-14End: 2026-04-06Updated: 2026-03-12

A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France

CompletedNCT05838664

PfizerAtrial Fibrillation

Start: 2023-07-07End: 2024-09-30Updated: 2025-12-24

Related Papers

Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.

2020-10-096 citations